Our study indicates that pathological deficiency of CHCHD6 is an inducer that acts upstream of both APP amyloidogenic processing and neural cholesterol accumulation, which provides a direct mechanistic explanation for the impact of mitochondrial damage on AD neuropathology. Here, CHCHD6 is linked to Alzheimer disease.